Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
Cardiopulmonary Resuscitation IV: Pharmacological Management01:25

Cardiopulmonary Resuscitation IV: Pharmacological Management

Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
Cardiac Catheterization IV: Nursing Management01:26

Cardiac Catheterization IV: Nursing Management

Nursing responsibilities before cardiac catheterization include:Assess for allergies and establish baseline health status.Before cardiac catheterization, assess the patient for allergies to contrast dye. Perform a comprehensive baseline assessment, including vital signs, heart and breath sounds, and a neurovascular assessment of the extremities, noting distal pulses, skin color, and temperature. Instruct the patient to fast for 8-12 hours before the procedure. Evaluate baseline laboratory...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Regulatory Roles of Long Non-Coding RNAs in Methotrexate Pharmacology: Mechanistic and Translational Insights.

Pharmaceutical research·2026
Same author

Murine Non-Transgenic Models of Alzheimer's Disease Pathology: Focus on Risk Factors.

Brain sciences·2025
Same author

Cross-species and mammal-to-mammal transmission of clade 2.3.4.4b highly pathogenic avian influenza A/H5N1 with PB2 adaptations.

Nature communications·2025
Same author

Paediatrics congenital heart disease is associated with plasma miRNAs.

Pediatric research·2024
Same author

Efficacy of Continuous vs. Intermittent Administration of Cefepime in Adult ICU Patients with Gram-Negative Bacilli Bacteremia: A Randomized Double-Blind Clinical Study.

Antibiotics (Basel, Switzerland)·2024
Same author

Decrease in the intensive care unit-acquired weakness with a multicomponent protocol implementation: A quasi-experimental clinical trial

Biomedica : revista del Instituto Nacional de Salud·2023
Same journal

[The cardiorenometabolic syndrome as a new clinical paradigm in precision medicine].

Archivos de cardiologia de Mexico·2026
Same journal

Safety and efficacy of dual-axis rotational vs standard coronary angiography: meta-analysis.

Archivos de cardiologia de Mexico·2026
Same journal

Influence of socioeconomic status on ST-segment elevation myocardial infarction in Mexico.

Archivos de cardiologia de Mexico·2026
Same journal

Right-sided juxtaposition of the left atrial appendage with orifice origin in unhabitual location: case report.

Archivos de cardiologia de Mexico·2026
Same journal

Data-driven atherosclerotic plaque profiles from QAngio-CT associated with functional impairments assessed with PET-CT.

Archivos de cardiologia de Mexico·2026
Same journal

Establishment and evolution of a cardio-oncology clinic in a tertiary care cardiology hospital in Mexico.

Archivos de cardiologia de Mexico·2026
See all related articles

Related Experiment Video

Updated: Jun 1, 2026

Postconditioning with Lactate-enriched Blood for Cardioprotection in ST-segment Elevation Myocardial Infarction
05:26

Postconditioning with Lactate-enriched Blood for Cardioprotection in ST-segment Elevation Myocardial Infarction

Published on: May 28, 2019

Myocardial postconditioning: anaesthetic considerations.

Pastor Luna-Ortiz1, Juan Carlos Torres, Gustavo Pastelin

  • 1Department of Pharmacology. Instituto Nacional de Cardiología Ignacio Chávez, México, D.F.

Archivos De Cardiologia De Mexico
|May 20, 2011
PubMed
Summary
This summary is machine-generated.

Brief coronary occlusions during reperfusion, known as postconditioning (PostC), protect the heart from injury. Pharmacological interventions, including anesthetics, also offer cardioprotection by targeting key molecular pathways.

More Related Videos

Delivery of Cardioactive Therapeutics in a Porcine Myocardial Infarction Model
07:20

Delivery of Cardioactive Therapeutics in a Porcine Myocardial Infarction Model

Published on: February 10, 2023

Pre-clinical Model of Cardiac Donation after Circulatory Death
06:26

Pre-clinical Model of Cardiac Donation after Circulatory Death

Published on: August 2, 2019

Related Experiment Videos

Last Updated: Jun 1, 2026

Postconditioning with Lactate-enriched Blood for Cardioprotection in ST-segment Elevation Myocardial Infarction
05:26

Postconditioning with Lactate-enriched Blood for Cardioprotection in ST-segment Elevation Myocardial Infarction

Published on: May 28, 2019

Delivery of Cardioactive Therapeutics in a Porcine Myocardial Infarction Model
07:20

Delivery of Cardioactive Therapeutics in a Porcine Myocardial Infarction Model

Published on: February 10, 2023

Pre-clinical Model of Cardiac Donation after Circulatory Death
06:26

Pre-clinical Model of Cardiac Donation after Circulatory Death

Published on: August 2, 2019

Area of Science:

  • Cardiovascular Physiology
  • Cellular Biology
  • Pharmacology

Background:

  • Ischemia-reperfusion injury (IRI) is a significant clinical problem following cardiac events.
  • Postconditioning (PostC) is a protective strategy involving brief interventions at the onset of reperfusion to mitigate IRI.
  • Pharmacological PostC utilizes specific agents to elicit similar protective effects.

Purpose of the Study:

  • To review the mechanisms of IRI and the protective pathways activated by PostC.
  • To explore the role of various mediators and signaling pathways in PostC.
  • To highlight the potential of pharmacological PostC, particularly anesthetics, in clinical settings.

Main Methods:

  • Review of existing literature on ischemia-reperfusion injury and postconditioning.
  • Analysis of signaling pathways involved in cardioprotection, including RISK and SAFE pathways.
  • Examination of pharmacological agents, such as volatile anesthetics and opioids, as potential PostC triggers.

Main Results:

  • PostC reduces reperfusion-induced injury, oxidant damage, and inflammation.
  • Key mediators like adenosine, glycine, and bradykinin are involved in PostC.
  • Signaling pathways including nitric oxide, protein kinase C, and RISK/SAFE pathways are activated by PostC.
  • Pharmacological agents, especially volatile anesthetics, demonstrate cardioprotective effects, acting as pharmacological PostC.

Conclusions:

  • PostC and pharmacological PostC offer promising strategies to protect the myocardium against reperfusion injury.
  • The protective mechanisms of PostC converge on inhibiting mitochondrial permeability transition pore opening.
  • Anesthetic-induced PostC holds significant potential for clinical application in operating rooms.